Dosimetry counts: molecular hypersensitivity may not drive pulmonary hyperresponsiveness.

Area of Science:

• Pulmonary Medicine
• Allergy and Immunology
• Respiratory Physiology

Background:

• Airway hyperresponsiveness (AHR) is a hallmark of asthma.
• The methacholine challenge test is commonly used to assess AHR in humans and rodent models.
• Existing dose-metric calculations may not fully capture physiological responses.

Purpose of the Study:

• To re-evaluate methacholine-induced airway hyperresponsiveness in mice.
• To investigate the impact of airway dimensions and physiology on AHR measurements.
• To reconcile discrepancies in AHR between different mouse strains.

Main Methods:

• Comparative analysis of methacholine challenge test results in B6C3F1 and Balb/c mice.
• Calculation of methacholine deposited mass based on airway dimensions (generations 1-6).
• Inclusion of airway constriction and pressure drop physiology in the analysis.

Main Results:

• The 12-fold difference in methacholine responsiveness between mouse strains diminished when accounting for deposited drug mass and airway physiology.
• Upper airway constriction demonstrated a greater impact on breathing resistance than lower airway constriction (generations 6-16).
• Physiological factors significantly influence the interpretation of AHR test results.

Conclusions:

• Standard methacholine challenge dose-metrics may overestimate AHR differences between individuals or strains.
• Airway dimensions and physiological responses are critical for accurate AHR assessment.
• This study offers insights into AHR variability and the mechanisms of breathing resistance in asthma.